Abstract
Genomic medicine has created a great deal of hope since the completion of the Human Genome Project (HGP). Genomic medicine promises disease prevention and early diagnosis in the context of precision medicine. Precision medicine as a scientific discipline has introduced as an evolution in medicine. The rapid growth of high-development technologies permits the assessment of biological systems. Study of the integrated profiles of omics, such as genome, transcriptome, proteome and other omics information lead to significant advances in personalized and precision medicine. In the context of precision medicine, pharmacogenomics can play an important role in order to discriminate responders and non-responders to medications and avoiding toxicity and achieving the optimum dose. So precision medicine in accordance with genomic medicine will transform medicine from conventional evidence-based medicine in the diagnosis and treatment towards precision based-medicine. In this review, we have summarized the related issues for genomic medicine and precision medicine.
Similar content being viewed by others
Abbreviations
- PGx:
-
Pharmacogenomics
- NHGRI:
-
National Human Genome Research Institute
- NGS:
-
Next-generation sequencing
- HGP:
-
Human Genome Project
- WES:
-
Whole Exome Sequencing
- GWAS:
-
Genome-Wide Association Studies
- LD:
-
Linkage disequilibrium
- indels:
-
Insertions and deletions
- CNVs:
-
Copy number variations
- DOE:
-
Department of Energy
- lncRNAs:
-
Long non-coding RNAs
- SNPs:
-
Single nucleotide polymorphisms
- TFs:
-
Transcription factors
- EWAS:
-
Epigenome-wide association studies
- PRS:
-
Polygenic risk scores
- PGS:
-
Polygenic scores
References
National Cancer Institute (NIH). NCI is the nation’s leader in cancer research. Available at: https://www.cancer.gov/.
Narad P, Kirthanashri S. Introduction to omics. Omics approaches, technologies and applications. Springer; 2018. p. 1–10.
Food and Drug Adminstration (FDA). Department of Health and Human Services. Table of pharmacogenomic biomarkers in drug labeling. Available at: https://www.fda.gov/drugs/scienceresearch/ucm572698.htm.
Roth SC. What is genomic medicine? J Med Libr Assoc. 2019;107(3):442–8.
Davies K. The era of genomic medicine. Clin Med (Lond). 2013;13(6):594–601.
Rubanovich CK, Cheung C, Mandel J, Bloss CS. Physician preparedness for big genomic data: a review of genomic medicine education initiatives in the United States. Hum Mol Genet. 2018;27(R2):R250–8.
Roden D, Tyndale R. Genomic medicine, precision medicine, personalized medicine: what’s in a name? Clin Pharmacol Ther. 2013;94(2):169–72.
Sykiotis GP, Kalliolias GD, Papavassiliou AG. Hippocrates and genomic medicine. Arch Med Res. 2006;37(1):181–3.
Raza S, Hall A. Genomic medicine and data sharing. Br Med Bull. 2017;123(1):35–45.
Manolio TA, Green ED. Leading the way to genomic medicine. Am J Med Genet C Semin Med Genet. 2014;166c(1):1–7.
Semiz S, Dujic T, Causevic A. Pharmacogenetics and personalized treatment of type 2 diabetes. Biochem Med (Zagreb). 2013;23(2):154–71.
Council NR. Toward precision medicine: building a knowledge network for biomedical research and a new taxonomy of disease. National Academies Press; 2011.
Ginsburg GS, Phillips KA. Precision medicine: From science to value. Health Aff. 2018;37(5):694–701.
Vailati-Riboni M, Palombo V, Loor JJ. What are omics sciences? Periparturient diseases of dairy cows. Springer; 2017. p. 1–7.
Hasin Y, Seldin M, Lusis A. Multi-omics approaches to disease. Genome Biol. 2017;18(1):1–15.
Subramanian I, Verma S, Kumar S, Jere A, Anamika K. Multi-omics data integration, interpretation, and its application. Bioinform Biol Insights. 2020;14:1177932219899051.
OMIM Gene Map Statistics 2019, Last updated February 1st. Available at: https://www.omim.org/statistics/geneMap.
Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, Baldwin J, et al. Initial sequencing and analysis of the human genome. Nature. 2001;409(6822):860–922.
Welter D, MacArthur J, Morales J, Burdett T, Hall P, Junkins H, et al. The NHGRI GWAS Catalog, a curated resource of SNP-trait associations. Nucleic Acids Res. 2013;42(D1):D1001–6.
Edwards SL, Beesley J, French JD, Dunning AM. Beyond GWASs: illuminating the dark road from association to function. Am J Hum Genet. 2013;93(5):779–97.
Flister MJ, Tsaih S-W, O’Meara CC, Endres B, Hoffman MJ, Geurts AM, et al. Identifying multiple causative genes at a single GWAS locus. Genome Res. 2013;23:1996–2002.
Witte JS. Genome-wide association studies and beyond. Annu Rev Public Health. 2010;31:9–20.
Ku CS, Loy EY, Salim A, Pawitan Y, Chia KS. The discovery of human genetic variations and their use as disease markers: Past, present and future. J Hum Genet. 2010;55(7):403–15.
Krulwich R, Lander E. Cracking the code of life. Public Broadcasting Service; 2001.
Collins FS, Patrinos A, Jordan E, Chakravarti A, Gesteland R, Walters L. New goals for the US human genome project: 1998–2003. Science. 1998;282(5389):682–9.
Collins F, Galas D. A new five-year plan for the US Human Genome Project. Science. 1993;262(5130):43–6.
Collins FS, Morgan M, Patrinos A. The Human Genome Project: lessons from large-scale biology. Science. 2003;300(5617):286–90.
Consortium IHGS. Finishing the euchromatic sequence of the human genome. Nature. 2004;431(7011):931.
Osoegawa K, Mammoser AG, Wu C, Frengen E, Zeng C, Catanese JJ, et al. A bacterial artificial chromosome library for sequencing the complete human genome. Genome Res. 2001;11(3):483–96.
Asakawa S, Abe I, Kudoh Y, Kishi N, Wang Y, Kubota R, et al. Human BAC library: construction and rapid screening. Gene. 1997;191(1):69–79.
Lodish H, Berk A, Zipursky SL, Matsudaira P, Baltimore D, Darnell J. Molecular cell biology. WH Freeman; 1995.
Pines M. The genes we share with yeast, flies, worms, and mice: new clues to human health and disease. Howard Hughes Medical Institute; 2001.
Cirulli ET, Goldstein DB. Uncovering the roles of rare variants in common disease through whole-genome sequencing. Nat Rev Genet. 2010;11(6):415.
Consortium IH. A haplotype map of the human genome. Nature. 2005;437(7063):1299.
Kennedy GC, Matsuzaki H, Dong S, Liu W-M, Huang J, Liu G, et al. Large-scale genotyping of complex DNA. Nat Biotechnol. 2003;21(10):1233.
Cargill M, Altshuler D, Ireland J, Sklar P, Ardlie K, Patil N, et al. Characterization of single-nucleotide polymorphisms in coding regions of human genes. Nat Genet. 1999;22(3):231.
Ke X, Cardon LR. Efficient selective screening of haplotype tag SNPs. Bioinformatics. 2003;19(2):287–8.
†The International HapMap C, Gibbs RA, Belmont JW, Hardenbol P, Willis TD, Yu F, et al. The International HapMap Project. Nature. 2003;426:789.
Consortium IH. The international HapMap project. Nature. 2003;426(6968):789.
Thorisson GA, Smith AV, Krishnan L, Stein LD. The international HapMap project web site. Genome Res. 2005;15(11):1592–3.
Haralambieva IH, Ovsyannikova IG, Pankratz VS, Kennedy RB, Jacobson RM, Poland GA. The genetic basis for interindividual immune response variation to measles vaccine: new understanding and new vaccine approaches. Expert Rev Vaccines. 2013;12(1):57–70.
Elmas A, Yang T-HO, Wang X, Anastassiou D. Discovering Genome-Wide Tag SNPs Based on the Mutual Information of the Variants. PloS One. 2016;11(12):e0167994.
Evans WE, McLeod HL. Pharmacogenomics—drug disposition, drug targets, and side effects. N Engl J Med. 2003;348(6):538–49.
Evans WE, Relling MV. Pharmacogenomics: translating functional genomics into rational therapeutics. Science. 1999;286(5439):487–91.
Hartl D, de Luca V, Kostikova A, Laramie J, Kennedy S, Ferrero E, et al. Translational precision medicine: an industry perspective. J Transl Med. 2021;19(1):1–14.
Yong SY, Raben TG, Lello L, Hsu SD. Genetic architecture of complex traits and disease risk predictors. Sci Rep. 2020;10(1):1–14.
Li R, Chen Y, Ritchie MD, Moore JH. Electronic health records and polygenic risk scores for predicting disease risk. Nat Revi Genet. 2020;21(8):493–502.
Zeggini E, Gloyn AL, Barton AC, Wain LV. Translational genomics and precision medicine: Moving from the lab to the clinic. Science. 2019;365(6460):1409–13.
Author information
Authors and Affiliations
Contributions
MH: Design the study and write the manuscript; NS, FKH, and EGH: Search and find the relevant articles and help to draft; AN and SE: Provide guidance to the research; HRAM: Revise the manuscript; BL: Develop the project. All authors will read and approved the final manuscript before submission.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Hasanzad, M., Sarhangi, N., Naghavi, A. et al. Genomic medicine on the frontier of precision medicine. J Diabetes Metab Disord 21, 853–861 (2022). https://doi.org/10.1007/s40200-021-00880-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40200-021-00880-6